• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>DRS

DRS

  1. All
  2. 3rd Party
  3. Investing
  1. C2N Diagnostics Expands Partnership with Washington University School of Medicine to Commercialize a Clinical Blood Test for Detection of Early Alzheimer’s Disease

    C2N Diagnostics Expands Partnership with Washington University School of Medicine to Commercialize a Clinical Blood Test for Detection of Early Alzheimer’s Disease

  2. Soligenix Announces Combination Vaccine for Ricin and Anthrax Achieves Simultaneous Protection

    Soligenix Announces Combination Vaccine for Ricin and Anthrax Achieves Simultaneous Protection

  3. Singapore's proposed changes to its secondary listings framework could help strengthen its position as a world financial centre, says BNY Mellon

    Singapore's proposed changes to its secondary listings framework could help strengthen its position as a world financial centre, says BNY Mellon

  4. Roger Ibbotson, Benoit Mandelbrot, and George Cooper

    Our distinguished economics panel debates the value of current risk models.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.